Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
14.56
-0.02 (-0.14%)
Oct 31, 2025, 4:00 PM EDT - Market closed
Ardent Health Revenue
Ardent Health had revenue of $1.65B in the quarter ending June 30, 2025, with 11.85% growth. This brings the company's revenue in the last twelve months to $6.20B, up 10.03% year-over-year. In the year 2024, Ardent Health had annual revenue of $5.97B with 10.29% growth.
Revenue (ttm)
$6.20B
Revenue Growth
+10.03%
P/S Ratio
0.33
Revenue / Employee
$248,941
Employees
24,900
Market Cap
2.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.97B | 556.59M | 10.29% |
| Dec 31, 2023 | 5.41B | 279.80M | 5.45% |
| Dec 31, 2022 | 5.13B | 259.29M | 5.32% |
| Dec 31, 2021 | 4.87B | 708.52M | 17.02% |
| Dec 31, 2018 | 4.16B | 1.16B | 38.79% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
ARDT News
- 11 days ago - Ardent Health Announces Third Quarter 2025 Results Conference Call and Webcast Date - Business Wire
- 5 weeks ago - Ardent Announces Successful Amendment and Extension of Term Loan Facility - Business Wire
- 7 weeks ago - Ardent Health, Inc. (ARDT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Ardent Health to Participate in September Investor Conferences - Business Wire
- 3 months ago - Ardent Health Reports Second Quarter 2025 Results - Business Wire
- 3 months ago - Ardent Health Announces Second Quarter 2025 Results Conference Call and Webcast Date - Business Wire
- 3 months ago - Ardent Health: The Best Prospect In An Industry That's Facing Challenges - Seeking Alpha
- 5 months ago - Ardent Health Partners, Inc. Updates Name to Ardent Health, Inc. - Business Wire